NCT00246129View on ClinicalTrials.gov

CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Kidney TransplantationKidney DiseasesKidney Failure
Interventions
DRUG

Campath

Monoclonal antibody induction therapy

DRUG

Daclizumab

Monoclonal antibody induction therapy

Trial Locations (1)

W12 OHS

West London Renal and Transplant Centre, 4th Floor Ham House, Hammersmith Hospital, London

All Listed Sponsors
lead

EMagnusson

OTHER

NCT00246129 - CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation | Biotech Hunter | Biotech Hunter